Mouse model of Epstein–Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mouse model of Epstein–Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 18, Pages 4751-4756
Publisher
Proceedings of the National Academy of Sciences
Online
2017-03-29
DOI
10.1073/pnas.1701836114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential
- (2017) Shi-Dong Ma et al. JOURNAL OF VIROLOGY
- Mouse model for acute Epstein–Barr virus infection
- (2016) Tristan Wirtz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hodgkin lymphoma: Pathology and biology
- (2016) Stephan Mathas et al. SEMINARS IN HEMATOLOGY
- The biology and treatment of plasmablastic lymphoma
- (2015) J. J. Castillo et al. BLOOD
- Evasion of affinity-based selection in germinal centers by Epstein–Barr virus LMP2A
- (2015) Takeharu Minamitani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma
- (2013) K. Fish et al. BLOOD
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
- (2012) Baochun Zhang et al. CELL
- Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
- (2012) M. R. Green et al. CLINICAL CANCER RESEARCH
- Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (LMP1) and LMP2A Function Cooperatively To Promote Carcinoma Development in a Mouse Carcinogenesis Model
- (2012) K. H. Y. Shair et al. JOURNAL OF VIROLOGY
- Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
- (2012) K. H. Y. Shair et al. mBio
- Epstein-Barr Virus LMP2A Reduces Hyperactivation Induced by LMP1 to Restore Normal B Cell Phenotype in Transgenic Mice
- (2012) Alexandra C. Vrazo et al. PLoS Pathogens
- Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
- (2011) J. Ouyang et al. BLOOD
- CXCR3 ligands: redundant, collaborative and antagonistic functions
- (2011) Joanna R Groom et al. IMMUNOLOGY AND CELL BIOLOGY
- Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
- (2011) J. I. Cohen et al. Science Translational Medicine
- Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation
- (2010) Q.-F. Liu et al. Transplant Infectious Disease
- Epstein–Barr virus LMP2A accelerates MYC-induced lymphomagenesis
- (2009) R Bultema et al. ONCOGENE
- Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis
- (2009) K. T. Bieging et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EBV LMP2A affects LMP1-mediated NF- B signaling and survival of lymphoma cells by regulating TRAF2 expression
- (2008) I. Guasparri et al. BLOOD
- Instructive Role of the Transcription Factor E2A in Early B Lymphopoiesis and Germinal Center B Cell Development
- (2008) Kyongrim Kwon et al. IMMUNITY
- Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection
- (2008) Thomas Powles et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now